MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 44 filers reported holding MIRATI THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $202,000 | -31.8% | 9,425 | +0.5% | 0.14% | -34.0% |
| Q4 2015 | $296,000 | -52.9% | 9,375 | -48.6% | 0.22% | -55.2% |
| Q3 2015 | $628,000 | +14.6% | 18,240 | +4.7% | 0.48% | +22.1% |
| Q2 2015 | $548,000 | +13.2% | 17,415 | +5.5% | 0.39% | +10.1% |
| Q1 2015 | $484,000 | +136.1% | 16,500 | +49.0% | 0.36% | +119.0% |
| Q4 2014 | $205,000 | – | 11,075 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |